MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$2,929,747
Free Cash flow
-$4,589,091
Unit: Dollar
Positive Cash Flow Breakdown
Change in fair value of derivati...
Proceeds from notes and converti...
Common stock, preferred stock, a...
Others
Negative Cash Flow Breakdown
Net loss
Repayments of note payable
Accounts payable and accrued exp...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Stock-based compensation
-
0
0
473,311
Net loss
-16,189,200
-5,231,251
-24,207,669
-13,348,123
Depreciation expense
47,882
66,807
66,966
135,498
Stock-based compensation from asset purchase
-
0
0
10,000
Amortization of intangible assets
834
833
833
1,667
Amortization of debt discount - note payable
24,687
60,000
234,167
1,412,530
Amortization of debt discount - note receivable
-
12,680
108,112
99,897
Change in fair value of derivative liability
11,800,798
-228
-162
-14,125
Loss on note exchange agreement
-
0
0
0
Redemptions of a-1 preferred stock
-
-
0
308,000
Impairment of evofem f-1 preferred stock
-
764,290
23,001,919
-
Change in fair value of evofem warrants
-25,004
-358,413
-2,511,781
63,211
Redemptions of c-1 preferred stock
-
-
-
7,027,065
Deposits
-
-183,112
28,752
128,274
Credit loss on evofem notes
-
-
350,000
-
Bargain purchase gain from purchase of evofem convertible notes
-
-328,071
-
-
Impairment of fixed assets
32,275
412,005
-
-
Cash from subscription receivable
-
149,027
-149,027
1,108,751
Modification of warrants for debt issuance costs
-
0
0
-
Accounts receivable
11,974
-39,182
-561
-3,692
New principal from extension of notes, net of debt discount
-
0
0
0
Prepaid expenses
-294,310
554,746
0
59,237
Disposal of fixed assets
-
0
-
-
Settlement liability
-
0
-
0
Other assets
-
-
75,229
-
Inventory
-9,289
-798
-1,045
-3,628
Settlement liability
-
-
0
-
Accounts payable and accrued expenses
-562,609
-4,012,540
931,660
-2,552,013
Net cash used in operating activities
-4,578,712
-9,245,673
-2,344,554
-14,098,132
Purchases of fixed assets
10,379
13,743
-
-
Investment in notes receivable and warrants
-
-
2,425,000
-
Investment in convertible notes receivable and warrants
-
0
-
2,425,000
Investment in evofem f-1 preferred stock
-
0
0
0
Repayments of note payable, related party
-
-185,000
0
-608,000
Net cash used in investing activities
-10,379
-13,743
0
-2,425,000
Proceeds from notes payable, related party
-
0
185,000
493,000
Proceeds from notes and convertible notes payable, net of offering costs
2,855,000
-483,001
170,000
1,504,019
Repayments of note payable
1,428,921
2,421,248
265,874
3,926,760
Common stock, preferred stock, and warrants issued for cash, net of issuance costs
603,261
16,789,941
2,560,449
24,777,835
Redemptions of a-1 preferred stock
369,996
308,000
-
-
Redemptions of c-1 preferred stock
-
1,554,745
7,343,697
-
Proceeds from exercises of warrants
-
0
0
-
Redemptions of d-1 preferred stock
-
0
-
-
Net increase in cash
-
2,874,920
-
-
Net cash provided by financing activities
1,659,344
12,294,974
2,183,916
16,013,780
Net increase (decrease) in cash
-
-
-669,990
-
Net decrease in cash
-2,929,747
2,874,920
-
-509,352
Cash at beginning of period
3,198,599
163,041
833,031
-
Cash at end of period
268,852
3,198,599
163,041
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from notes and
convertible notes payable,...
$2,855,000
Common stock,
preferred stock, and...
$603,261
Net cash provided by
financing activities
$1,659,344
Canceled cashflow
$1,798,917
Net decrease in cash
-$2,929,747
Canceled cashflow
$1,659,344
Change in fair value of
derivative liability
$11,800,798
Prepaid expenses
-$294,310
Depreciation expense
$47,882
Impairment of fixed assets
$32,275
Amortization of debt discount
- note payable
$24,687
Inventory
-$9,289
Amortization of intangible
assets
$834
Repayments of note payable
$1,428,921
Redemptions of a-1 preferred
stock
$369,996
Net cash used in
operating activities
-$4,578,712
Canceled cashflow
$12,210,075
Net cash used in
investing activities
-$10,379
Net loss
-$16,189,200
Accounts payable and
accrued expenses
-$562,609
Change in fair value of
evofem warrants
-$25,004
Accounts receivable
$11,974
Purchases of fixed assets
$10,379
Buy us a coffee
Aditxt, Inc. (ADTX)
Aditxt, Inc. (ADTX)